Earnings Call · Q2 FY2021·2021-01-28

Q2 21EPS +10.16%·Rev n/aQ1 21EPS +23.30%·Rev n/aQ4 20EPS +24.30%·Rev n/aQ3 20EPS +19.44%·Rev n/a⚠ consensus missing

RESMED INC RMD

Amy Wakeham — Vice President, Investor Relations

Mick Farrell — Chief Executive Officer

Brett Sandercock — Chief Financial Officer

−6.7%1d on move date3d−4.3%5d−5.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RMD calls or request research access.

More RMD calls Browse calls Request research access